Reach Us +32-28-08-6657


Persistent Preformed Donor-Specific Antibodies and Clinical Risks of de novo Donor-Specific Antibody Development after Kidney Transplantation

Methods used to identify alloantibodies have become increasingly more sensitive and specific over time, evolving from complement-dependent cytotoxicity crossmatch (CDCXM), flow cytometry crossmatch (FCXM), and solid phase assays performed using Luminex platforms.


Shigeru Satoh, Nobuhiro Fujiyama and Mitsuru Saito

Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
Flyer image
Abstracted/Indexed in
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • Secret Search Engine Labs